TheEdgeResearch
Home / Stocks / ETIGX

Parametric Tax-Managed International Equity Fund Investor Class (ETIGX)

NASDAQ Financial Services Asset Management
$12.44 ▲ +0.00%
Market Cap
$36.4M
Sector
Financial Services
Industry
Asset Management
Beta
1.02
52-Wk Range
11.76-13.64
CEO
—
Country
US
Currency
USD

Parametric Tax-Managed International Equity Fund Investor Class operates in the Asset Management industry of the Financial Services sector, headquartered in Boston, US. The stock last traded at $12.44, up 0.00% on the session, giving a market capitalisation of $36.4M. On trailing twelve-month figures it carries a trailing P/E of 9.80, a net margin of 687.6%. Its beta of 1.02 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
9.80
Price / Sales
1.26
Price / Book
1.07
EV / EBITDA
0.19
Gross margin
100.0%
Operating margin
31.0%
Net margin
687.6%
Return on equity
—
Debt / equity
0.00
Current ratio
2.87
Dividend yield
2.4%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Global Market
Employees
—
IPO date
1998-04-22
Headquarters
Boston, US
About Parametric Tax-Managed International Equity Fund Investor Class

Under typical market conditions, this fund is committed to investing a minimum of 80% of its net assets (including any capital borrowed for investment purposes) into a varied portfolio of equity securities, in accordance with its "80% Policy." Its primary focus is on common stocks issued by companies headquartered in developed nations outside of the United States, specifically those represented within the MSCI Europe, Australasia, Far East (MSCI EAFE) Index. The fund's holdings may also encompass other equity instruments, such as depositary receipts.

Comparable companies

Parametric Tax-Managed International Equity Fund Investor Class is most often compared with the following Financial Services names:

ACWDXMNWAXRSRFXRYAWXRYCIXRYPDXSAOAXSAOIXSGPIXWAGTX
More research on ETIGX
ETIGX technical analysis ETIGX TheEdge Score Compare against peers
Open full interactive analysis & DCF →